IMMUNOTHERAPY IN ONCOLOGY
The immunotherapy treatment developed by URODELIA is a personalized medicine process that purifies abnormal molecules synthesized by cancer cells in order to gain their recognition by the patient’s immune system. this makes it possible to obtain an eradication of tumor cells by the immune cells of patients without significant side effects.
This personalized medicine process is designed to stimulate the patient’s cellular immune system against its own tumor.
This personalized immunotherapy treatment is neither a chemotherapy nor a hormone therapy.
1/ Immunotherapy treatment:
Immunotherapy as a tool to fight against cancer is a growing research area, and is found today in more than 700 scientific publications in specialized journals in 2016.
2/ Cancer treatment:
To fight against cancer, the treatment developed by URODELIA relies on the development characteristics of a tumor process.
Cancer is characterized by cellular transformation and genetic instability. This results in the presence of different cell clones with extreme antigenic variability and is accompanied by various biological phenomena leading to an escape of the tumor cells to the immune surveillance.
Faced with this phenomenon, the immune system becomes unable to control cell proliferation: it must be re-educated to recognize and specifically address the patient’s tumor cells.
This is the mode of action of the therapy developed by URODELIA.
3/ Personalized treatment:
Due to its composition, the treatment developed by URODELIA reverses the immune response to cancer cells.
This treatment is manufactured from the biopsy of the patient’s tumor. The exact reflection of the antigenic identity of the tumor is thus obtained. The antigenic component of this treatment corresponds to the proteins of heat shock or HSP.
The treatment contains a vector composed of hydroxyapatite particles. These particles represent a safe vector as successfully used in human medicine for over 30 years. This treatment uses the ability of hydroxyapatite to adsorb HSPs and vectorize them within antigen presenting cells.
This composition activates the immune system through a specific response and non-specific.
The treatment developed by URODELIA is a biotherapy with no toxic residues, based on multiple complex biological mechanisms.